Drug use evaluation of ipratropium bromide at two tertiary referral hospitals in Brisbane.


Autoria(s): Cardiff, L. M.; Coombes, J.; Matthews, J.; Poulier, M. V.; Tett, S.E.
Data(s)

01/01/2001

Resumo

Objective: To assess the appropriateness of ipratropium bromide prescribing in two tertiary referral hospitals. Method: Criteria for optimal use were developed based on current literature and modified after consultation with respiratory physicians and clinical pharmacists. A prospective review of prescribing was performed over a 2-month period to assess conformity to these criteria. Results: Information was collected from 84 patients; 5% were receiving inhalers and 96% nebuliser therapy (one patient used both). 77% of patients (n = 65) had a principal diagnosis of chronic obstructive pulmonary disease, 14% (n = 12) asthma and 8% (n = 7) had neither diagnosis. 75% of patients were using ipratropium outside the guidelines. The major areas where the guidelines were not met were a lack of therapeutic justification, use of inappropriate doses, and use of an inappropriate delivery device. Feedback and educational interventions were designed and delivered based on the data obtained. Conclusions: There was widespread use of ipratropium outside the developed guidelines. Interventions in specific areas could lead to significant improvements in the use of this high cost drug

Identificador

http://espace.library.uq.edu.au/view/UQ:59183

Idioma(s)

eng

Publicador

Society of Hospital Pharmacists of Australia

Palavras-Chave #ipratropium bromide #Drug use evaluation #Tertiary referral hospital #C1 #320503 Clinical Pharmacology and Therapeutics #730199 Clinical health not specific to particular organs, diseases and conditions
Tipo

Journal Article